Episode Details
Back to EpisodesEARNINGS — Around the Horn: LLY, MRK, ALGN, HSY
Published 3 weeks ago
Description
Eli Lilly (Hannah): revenue $24.397B (+39%), non-GAAP EPS $7.48, Mounjaro $10.723B (+65%), Zepbound $5.352B (+49%), FY revenue guide raised to $91-92B. Reaction +4.09% — fair. Merck (Hannah): non-GAAP EPS $2.49, worldwide sales $18.086B (+5%); the $2.77-2.82 FY guide embeds $6.05/sh of one-time charges — read the footnote, plus ~$550M pull-forward quality note. Reaction +2.17% — fair. Align (Hannah): revenue $999.7M (+1.8%), small beat; FY guide CUT to $4.11-4.13B; CEO Hogan steps down Dec 31, 2026, Jennifer Davis succeeds. Reaction +0.90% — fair for now. Hershey (Stan): adj EPS $2.64 vs $2.11 (+25%), guide raised; price +11 pts / volume -10 pts bridge, cocoa relief arriving. Reaction -2.45% — the volume bill, charged fairly. All figures primary-release verified. This information is for informational purposes only. This is not financial advice. Please do your own research.